Prabuddha Mukherjee,1 Edita Aksamitiene,1 Aneesh Alex,2,1 Derek Shi,1 Darold R. Spillman Jr.https://orcid.org/0000-0001-9946-2659,1 Marina Marjanovic,1 Michael Fazio,3 Punit Seth,3 Kendal Frazier,1 Steve R. Hood,2,1 Stephen A. Boppart1
1Univ. of Illinois (United States) 2GlaxoSmithKline (United States) 3Ionis Pharmaceuticals, Inc. (United States)
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
Antisense oligonucleotides (ASOs), a novel paradigm in modern therapeutics, modulate cellular gene expression by binding to complementary RNA sequences. Triantennary N-acetyl galactosamine (GN)-conjugated ASOs show greatly improved potency via Asialoglycoprotein receptor (ASGR)-mediated uptake in hepatocytes. Here, we compare the uptake kinetics and subsequent distribution of untargeted ASOs to that of GN-ASOs in mouse macrophages and hepatocytes using simultaneous coherent anti-Stokes Raman scattering (CARS) and two-photon excited fluorescence imaging. While the CARS modality captured the changing lipid distributions and overall morphology of the cell, two-photon fluorescence imaging measured the uptake and the subsequent distribution of the fluorescently labeled (Alexa-488) ASOs inside the cells.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.
The alert did not successfully save. Please try again later.
Prabuddha Mukherjee, Edita Aksamitiene, Aneesh Alex, Derek Shi, Darold R. Spillman Jr., Marina Marjanovic, Michael Fazio, Punit Seth, Kendal Frazier, Steve R. Hood, Stephen A. Boppart, "Differential uptake of antisense oligonucleotides in mouse hepatocytes and macrophages revealed by simultaneous 2P-fluorescence and CARS," Proc. SPIE 11624, Visualizing and Quantifying Drug Distribution in Tissue V, 116240E (5 March 2021); https://doi.org/10.1117/12.2578037